Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets is used for the treatment of patients with genotype 3 chronic hepatitis C virus infection

Hepcinat Plus, the generic fixed dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg Tablet, for the treatment of patients with chronic hepatitis C virus (HCV) infection. A generic fixed dose combination drug of Sofosbuvir and Daclatasvir for treatment of Hepatitis C
Brand Drug Name: Hepcinat Plus
Generic Name (Active Ingredient): Sofosbuvir 400mg & Daclatasvir 60mg
Indian Manufacturer: Natco Pharma Ltd
Retail Pack: 28 in a bottle

Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets medicine cost price in India.

The order for Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Indian generic medicine manufacturer Natco pharma added another milestone in its hepatitis c portfolio. On, 02 July 2018, the company also launches the combination of two generic hep c drugs (Sofosbuvir 400mg and Daclatasvir 60mg) in a single tablet/bottle pack under its brand name of Hepcinat Plus in India.

Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets

Generic Name: Daclatasvir and Sofosbuvir

Hepcinat Plus (Daclatasvir + Sofosbuvir)

Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets is available.

Get In Touch

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi are legitimate consultant and facilitator in India, group of highly qualified pharma professionals. Specialized in Oncology and other pharma products. Helped more than 6,000 patients. Registration Number: 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient to get access of anti cancer medicines which is not available in India.

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support


Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets on prescription and Import License in Patient's Name only.

For overseas patients, Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets can be made available in Send your enquiry to find Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets.

For Hepcinat Plus (Daclatasvir and Sofosbuvir) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions

Natco Pharma launches Hepcinat Plus in India For More Details